14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.24 $11.93 Tuesday, 23rd Apr 2024 FOLD stock ended at $10.71. This is 1.02% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 2.25% from a day low at $10.68 to a day high of $10.92.
90 days $10.24 $14.03
52 weeks $9.70 $14.57

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
Mar 23, 2021 $10.45 $10.45 $10.15 $10.19 2 245 863
Mar 22, 2021 $10.25 $10.55 $10.10 $10.44 2 543 914
Mar 19, 2021 $10.20 $10.42 $10.13 $10.25 5 284 087
Mar 18, 2021 $10.40 $10.54 $10.09 $10.16 2 993 900
Mar 17, 2021 $10.34 $10.65 $10.31 $10.54 3 115 255
Mar 16, 2021 $10.88 $10.95 $10.34 $10.50 3 637 402
Mar 15, 2021 $10.81 $10.91 $10.63 $10.80 2 627 261
Mar 12, 2021 $10.62 $10.80 $10.49 $10.78 2 086 267
Mar 11, 2021 $10.59 $10.83 $10.39 $10.79 3 819 457
Mar 10, 2021 $10.57 $10.69 $10.21 $10.39 3 499 701
Mar 09, 2021 $10.31 $10.71 $10.23 $10.40 3 075 103
Mar 08, 2021 $10.55 $10.76 $10.06 $10.10 3 382 112
Mar 05, 2021 $10.51 $10.51 $9.70 $10.48 4 522 876
Mar 04, 2021 $10.65 $10.90 $10.05 $10.35 4 743 726
Mar 03, 2021 $11.21 $11.28 $10.64 $10.66 4 789 946
Mar 02, 2021 $11.77 $11.78 $11.07 $11.17 5 012 323
Mar 01, 2021 $12.41 $12.49 $11.69 $11.79 5 653 905
Feb 26, 2021 $12.03 $12.30 $11.68 $12.28 5 183 348
Feb 25, 2021 $11.94 $12.19 $11.69 $11.92 4 573 393
Feb 24, 2021 $11.95 $12.12 $11.70 $11.89 4 735 420
Feb 23, 2021 $11.57 $12.07 $11.28 $11.96 5 410 230
Feb 22, 2021 $12.07 $12.15 $11.82 $11.86 6 704 599
Feb 19, 2021 $11.89 $12.27 $11.76 $12.22 4 864 079
Feb 18, 2021 $12.07 $12.08 $11.62 $11.87 6 279 018
Feb 17, 2021 $12.01 $12.19 $11.76 $12.14 6 227 772
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT